-
Kenya's economy faces climate change risks: World Bank
-
Three die on Atlantic cruise ship from suspected hantavirus: WHO
-
Two die in 'respiratory illness' outbreak on Atlantic cruise ship
-
More Nepalis drive electric, evading global fuel shocks
-
Latecomer Japan eyes slice of rising global defence spending
-
German fertiliser makers and farmers struggle with Iran war fallout
-
OPEC+ to make first post-UAE production decision
-
Massive crowds fill Rio's Copacabana beach for Shakira concert
-
US airlines step up as Spirit winds down
-
Aviation companies step up as Spirit winds down
-
'Bookless bookstore': audio-only book shop opens in New York
-
Venezuelan protesters call government wage hike a joke
-
S&P 500, Nasdaq end at fresh records on tech earnings strength
-
Pope names former undocumented migrant as US bishop of West Virginia
-
Trump says will raise US tariffs on EU cars to 25%
-
ExxonMobil CEO sees chance of higher oil prices as earnings dip
-
After Madonna and Lady Gaga, Shakira set for Rio beach mega-gig
-
King Charles gets warm welcome in Bermuda after whirlwind US visit
-
Coe hails IOC gender testing decision
-
Baguettes take centre stage on France's Labour Day
-
Iran offers new proposal amid stalled US peace talks
-
French hub monitors Hormuz tensions from afar
-
Oil steady after wild swing, stocks diverge in thin trading
-
Chinese swimmer Sun Yang reports cyberbullying to police
-
Iran activates air defences as Trump faces congressional deadline
-
India's cows offer biogas alternative to Mideast energy crunch
-
Crude edges up after wild swing, stocks track Wall St rally
-
Formerra Appoints Matt Borowiec as Chief Commercial Officer
-
New Princess Diana documentary promises her own words
-
Oil slumps after hitting peak, US indices reach new records
-
Venezuela leader hikes minimum wage package by 26%
-
Apple earnings beat forecasts on iPhone 17 demand
-
Bangladesh signs biggest-ever plane deal for 14 Boeings
-
Musk grilled on AI profits at OpenAI trial
-
Venezuela opens arms to world with Miami-Caracas flight
-
US Congress votes to end record government shutdown
-
First direct US-Venezuela flight in years arrives in Caracas
-
Just telling nations to quit fossil fuels 'not realistic': COP31 chief
-
Trump hails 'greatest king' Charles as state visit wraps up
-
Drivers help study road-trip mystery: what became of bug splats?
-
Oil strikes 4-year peak, stocks rise
-
Iran's supreme leader defies US blockade as oil prices soar
-
White House against Anthropic expanding Mythos model access: report
-
Oil crisis fuels calls to speed up clean energy transition
-
European rocket blasts off with Amazon internet satellites
-
Nigerian airlines avert shutdown as Mideast war hikes fuel prices
-
ArcelorMittal boosts sales but profits squeezed
-
German growth beats forecast but energy shock looms
-
Air France-KLM trims 2026 outlook over Middle East war impact
-
Oil surges 7% to top $126 on Trump blockade warning
Germans turn to health apps as insurers foot the bill
German doctors are increasingly prescribing smartphone health apps alongside pills and therapy to patients, marking a growing trend towards digital healthcare.
Civil servant Mona Noe, 30, has long kept close watch over her diet in order to reduce cramps and bloating caused by irritable bowel syndrome.
Noe managed to persuade her doctor to prescribe her the app Cara Care, where she receives wellness tips and keeps a food diary to identify her pain triggers.
"It is difficult to do it by yourself," she said, preparing a vegetable stir fry without peppers or tomatoes at her home in Schleiden in western Germany, as per the app's instructions.
"The app has transformed my cooking by helping me avoid certain foods."
Applications that help patients quit smoking, fight obesity or improve their mental health often cost hundreds of euros a month, but insurance companies are helping by footing the bill.
The programme Noe uses is one of 56 now covered by German health insurers, signalling the country's turn towards digital health over traditional pen and paper options.
- 'Around the clock' -
The digital health tools, known as "DiGA" in Germany, have been available on prescription since 2020, typically on three-month renewable subscriptions.
In the five years since the programme began, more than one million prescriptions have been written, according to a study by digital healthcare sector association SVDGV.
Nearly 60 percent of doctors in Germany have prescribed at least one DiGA, and the number of prescriptions written for them in 2024 was up by 85 percent from the previous year.
Johannes Patze, a doctor in Frankfurt, said he prescribes them "almost daily" -- particularly for mental health support while patients are on a waiting list for a therapy appointment.
The apps provide patients with personalised mood tracking, online consultations with professionals, meditation sessions and motivational notifications.
The benefit, Patze said, is that "they're available around the clock, 24/7".
But they come with a cost. A three-month health app subscription costs 600 euros ($705) on average.
Health insurers have paid out 234 million euros for subscription services since 2020.
- 'Easing the burden' -
Germany's Association of Statutory Health Insurance Funds has criticised "excessive" application pricing and warns that there is little hard evidence to back up how effective they are.
But Patze told AFP that the apps could prove a reliable way of lowering healthcare costs in years to come.
Germany spent 326.9 billion euros on healthcare in 2024 -- higher than in previous years and partly due to an ageing population.
"The costs are probably lower in the long run since patients are better taken care of," said Patze.
Digital health consultant Henrik Matthies agreed.
"It's an upfront cost," he said, "but it helps patients get back to work sooner, easing the burden on the healthcare system."
The success of health apps in Germany is partly down to a fast-track approval process that is unusual in a country often mocked for its tedious bureaucracy.
App developers can obtain provisional approval for a programme within three months of applying. They then have a year to demonstrate its clinical effectiveness.
This speedy process "was a catalyst" for the system, Matthies said. Of 228 applications made in the past five years, 43 have received full approval and 13 are still under review.
A.Mykhailo--CPN